The OncologyAI Registry is a publicly curated database that catalogs AI-based diagnostic, predictive, and prognostic tools utilized in U.S. oncology. It provides comprehensive information on each tool's regulatory status, clinical evidence, and deployment signals, serving as a centralized reference for researchers, clinicians, regulators, payers, and journalists. The registry is updated quarterly to ensure the inclusion of the latest advancements in oncology AI.
Key Features and Functionality:
- Comprehensive Database: Offers detailed entries on AI tools, including their regulatory approvals, clinical validations, and real-world deployment data.
- User-Friendly Interface: Allows users to search and filter tools based on various criteria such as cancer type, regulatory status, and modality.
- Open Data Access: Provides open data under the CC BY 4.0 license, promoting transparency and collaboration within the oncology community.
Primary Value and Problem Solved:
The OncologyAI Registry addresses the challenge of navigating the rapidly evolving landscape of AI applications in oncology. By consolidating critical information into a single, accessible platform, it empowers stakeholders to make informed decisions regarding the adoption and implementation of AI tools in clinical practice, thereby enhancing patient care and advancing cancer research.